THE INVESTOR'S GUIDE TO WARRANTS:
Capitalize on the Fastest Growing Sector of the
Stock Market, Second Edition (Hardcover)
by Andrew McHattie Rating: ISBN-10: 027303751X
Quick Links:
Back to Home Page Back to Warrant Sheets
Back to Expired Warrants
Address: 200 - 4040 Civic Center Dr
San Rafael CA USA 94903
Phone: 888 861 2008
Web Site:
https://claritaspharma.com
Warrant Symbol - CLAS.WT.B
Number Trading - 167,516,000
Expiration Date - April 26, 2022
Cusip - 180634 13 1
Exercise Price - $0.065
Warrant Symbol - CLAS.WT.A
Number Trading - 19,533,000
Expiration Date -
Aug. 8, 2021
Cusip - 180634 14 9
Exercise Price - $0.155
Warrants called to trade news:
Claritas Pharma 1:20 share
rollback
2021-07-21 14:22 ET -
Rollback
Pursuant to a special resolution
passed by shareholders on June 17,
2021, the company has consolidated
its capital on a one-new-for-20-old
basis. The name of the company has
not been changed.
Series of warrants (Series A
warrants) set to expire on Aug. 8,
2021
Trading symbol: CLAS.WT.A
(unchanged)
Cusip No.: 180634 14 9 (new)
Effective at the opening on July 23,
2021, the exercise price for the
Series A warrants of the company
will be $3.10 per common share on a
postconsolidated basis.
Series of warrants (Series B
warrants) set to expire on April 26,
2022
Trading symbol: CLAS.WT.B
(unchanged)
Cusip No.: 180634 13 1 (new)
Effective at the opening on July 23,
2021, the exercise price for the
Series B warrants of the company
will be $1.30 per common share on a
postconsolidated basis.
© 2022 Canjex Publishing Ltd. All
rights reserved.
Claritas Pharmaceuticals
name change from Kalytera
2021-04-08 14:06 ET - Change Name
Effective at the opening on Monday,
April 12, 2021, the common shares
and warrants of Claritas
Pharmaceuticals Inc. will commence
trading on TSX Venture Exchange, and
the common shares and warrants of
Kalytera Therapeutics Inc. will be
delisted. The company is classified
as a "research and development in
the life sciences" company.
Series of warrants set to expire on
Aug. 8, 2021
Trading symbol: CLAS.WT.A (new)
Cusip No.: 180634 11 5 (new)
Series of warrants set to expire on
April 26, 2022
Trading symbol: CLAS.WT.B (new)
Cusip No.: 180634 12 3 (new)
© 2022 Canjex Publishing Ltd. All
rights reserved.
Kalytera changes name to
Claritas Pharmaceuticals
2021-04-08 17:25 ET - News Release
Kalytera Therapeutics Inc. is
changing its name to Claritas
Pharmaceuticals Inc. The name change
will become effective and the common
shares of the company will begin
trading under the new name effective
on April 12, 2021. The name change
is subject to final TSX Venture
Exchange approval.
The company's new Cusip numbers,
ISINs and ticker symbols for the
company's active listed securities
under its new name are as follows.
Warrants designated as WT:
ISIN: CA 180634 11 5 4;
Cusip No.: 180634 11 5;
Ticker symbol: CLAS.WT.A.
Warrants designated as WTS22:
ISIN: CA 180634 12 3 8;
Cusip No.: 180634 12 3;
Ticker symbol: CLAS.WT.B.
We seek Safe Harbor.
© 2022 Canjex Publishing Ltd. All
rights reserved.
- Expiration Date: The last day the warrants can be exercised. If warrants aren't going to be exercised then they must be sold the day before the expiry date. The longer the time to expiry the more valuable the warrants.
- Leverage: A measure of how much you can increase your exposure to a share if you bought warrants instead of making a direct investment. It is the current share price divided by the current price of the warrant.
- Intrinsic Value: The difference between the exercise price and the actual trading price of the common stock. Once the common has gone over the exercise price, the warrants are "In the Money."
- Volatility: The higher the volatility rating, the higher the price of the warrant. Historical volatility is calculated by using the standard deviation of an underlying stock price over a specific period.
- Time Value: The difference between the current warrant price and its intrinsic value. Interpreted as the consideration paid for the advantage the warrant buyer has over the direct investor.
